Approaches for Estimating Minimally Important Differences Ron D. Hays, Ph.D. January 12, 2004 (8:50-9:10am) Minimal Clinically Important Differences in.

Slides:



Advertisements
Similar presentations
RAHelp.org: An online intervention for rheumatoid arthritis Shigaki, C.L., 1 Smarr, K., 2,3 Siva, C., 3 Ge, B., 4 Musser, D., 5 Johnson, R. 6 1 Dept. Health.
Advertisements

An Overview of Minimally Important Difference Estimation in Health-Related Quality of Life Studies Ron D. Hays, Ph.D. October 14, 2004,
ASSESSING RESPONSIVENESS OF HEALTH MEASUREMENTS. Link validity & reliability testing to purpose of the measure Some examples: In a diagnostic instrument,
Sleep, Pain, and Fatigue in Ehlers-Danlos Syndrome Ehlers-Danlos National Foundation Learning Conference August 9, 2012 Susan Cordes, MS, CGC.
Supported by grants from: National Human Genome Research Institute (ELSI) HG/AG (The REVEAL Study); National Institute on Aging AG (The MIRAGE.
15-minute Introduction to PROMIS Ron D. Hays, Ph.D UCLA Division of General Internal Medicine & Health Services Research Roundtable Meeting on Measuring.
So You Want to Do Comparative Effectiveness Research? The Nuts and Bolts of CER.
Why Patient-Reported Outcomes Are Important: Growing Implications and Applications for Rheumatologists Ron D. Hays, Ph.D. UCLA Department of Medicine RAND.
EPIDEMIOLOGY. General Prevalence of Joint Pain Age-sex adjusted to the 2000 United States (US) standard population. Source: National Health Interview.
BURDEN OF ILLNESS. Overview Burden of Low Back Pain Number one cause of work-related disability 1 2 nd most common reason (after respiratory illness)
2000 IKDC SUBJECTIVE KNEE EVALUATION FORM
A Guide to Rheumatoid Arthritis for Legislators Rheumatoid Arthritis Policy Resource Center.
Dobson DaVanzo & Associates, LLC Vienna, VA Prostate Cancer Patients Report on Benefits of Proton Therapy: Follow- on.
Social and Behavioral Sciences Assignment 2
Health Policy and Management Assignment 1 Health-Related Quality of Life (HRQOL) Surveillance Summary Policy Brief.
MUSCULOSKELETAL DISEASES National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
1 Health-Related Quality of Life Ron D. Hays, Ph.D. - UCLA Department of Medicine: Division of General Internal Medicine.
Basic Methods for Measurement of Patient-Reported Outcome Measures Ron D. Hays, Ph.D. UCLA/RAND ISOQOL Conference on.
“A Critical Look at Health-Related Quality of Life Measures” SGIM Annual Meeting Ron D. Hays May 2, 2003 (12:30-1:30 pm)
Arthritis Facts. Leading Causes of Disability Among U.S. Adults, 1999 Among U.S. Adults, 1999 Arthritis is the leading cause of disability in the United.
Chronic Low Back Pain Gregory E. Hicks, PT, PhD University of Delaware.
A Comprehensive Approach to the Measurement of Health Outcomes Ron D. Hays, Ph.D. UCLA Department of Medicine November 25, 2008 K30 Track II Module Gonda.
Is the Minimally Important Difference Really 0.50 of a Standard Deviation? Ron D. Hays, Ph.D. June 18, 2004.
RESPONSE TO ANTIDEPRESSANT MEDICATION, COGNITIVE BEHAVIOR THERAPY AND PLACEBO IN CHRONIC TENSION-TYPE HEADACHE VARIES WITH PSYCHIATRIC COMORBIDITY & HEADACHE.
University of Minnesota Medical Technology Evaluation and Market Research Department of Healthcare Management Course: MILI/PUBH 6589 Spring Semester, 2013.
MS: A Perspective on the African American Experience Mary D. Hughes, MD Medical Director, Neuroscience Associates University Medical Group Greenville Hospital.
1 10/12/2015 Health-Related Quality of Life Assessment Health-Related Quality of Life Assessment Ron D. Hays, Ph.D. November 27, 2002 (8:30-9:30.
1 Assessing the Minimally Important Difference in Health-Related Quality of Life Scores Ron D. Hays, Ph.D. UCLA Department of Medicine October 25, 2006,
1 10/19/2015  Course materials copyrighted 2003 by Ron D. Hays A Comprehensive Approach to the Measurement of Health Outcomes Ron D. Hays, Ph.D. UCLA.
Evaluating Health-Related Quality of Life Measures June 12, 2014 (1:00 – 2:00 PDT) Kaiser Methods Webinar Series Ron D.Hays, Ph.D.
TAP PHARMACEUTICAL PRODUCTS INC. June 2, Arthritis Drugs Advisory Committee TAP Pharmaceutical Products Inc. June 2, 2004.
Another Perspective on PRO Content in Clinical Practice Ron D. Hays, Ph.D. University of California, Los Angeles June 25, 2007.
Development of Physical and Mental Health Summary Scores from PROMIS Global Items Ron D. Hays ( ) UCLA Department of Medicine
Measuring Health-Related Quality of Life
Overview of Health-Related Quality of Life Measures May 22, 2014 (1:00 – 2:00 PDT) Kaiser Methods Webinar Series 1 Ron D.Hays, Ph.D.
1 Session 6 Minimally Important Differences Dave Cella Dennis Revicki Jeff Sloan David Feeny Ron Hays.
Structural Equation Modeling (SEM) Ron D. Hays, Ph.D. November 15, 2010, 15:01-15:59pm UCLA RCMAR/EXPORT Seminar Series.
1 12/3/2015 Measuring Self-Reported Health Ron D. Hays, Ph.D. UCLA GIM & HSR November 27, 2007 (9:00-10:00 am) Gonda Building (Room 1357)
Rheumatoid Arthritis.
EQ-5D and SF-36 Quality of Life Measures in Systemic Lupus Erythematosus: Comparisons with RA, Non-Inflammatory Disorders (NIRD), and Fibromyalgia (FM)
Objective Measures of Physical Performance in Chronic GVHD: Adults Lynn H. Gerber, M.D. National Institutes of Health Bethesda, MD.
Quality of life and its health- relations. Definitions.
Depressive Symptoms in Primary Care: Recognition and Assessment Sudha Prathikanti, MD UCSF Department of Psychiatry.
Considerations in Comparing Groups of People with PROs Ron D. Hays, Ph.D. UCLA Department of Medicine May 6, 2008, 3:45-5:00pm ISPOR, Toronto, Canada.
Patient-Reported Physical Functioning Ron D. Hays November 27, 2012 (11:15-11:30) UCLA Department of Medicine MCID for Orthopaedic Devices Silver Springs,
Evaluating Health-Related Quality of Life Measures Ron D. Hays, Ph.D. UCLA GIM & HSR February 9, 2015 (9:00-11:50 am) HPM 214, Los Angeles, CA.
Reader’s Digest Introduction to Health-Related Quality of Life Ron D. Hays, Ph.D. UCLA Department of Medicine April 25, 2008 (Signature Grand) Nova Southeastern.
Estimating Minimally Important Differences on PROMIS Domain Scores Ron D. Hays UCLA Department of Medicine/Division of General Internal Medicine & Health.
Evaluating Multi-Item Scales Health Services Research Design (HS 225B) January 26, 2015, 1:00-3:00pm CHS.
Health-Related Quality of Life in Outcome Studies Ron D. Hays, Ph.D UCLA Division of General Internal Medicine & Health Services Research GCRC Summer Session.
Health-Related Quality of Life (HRQOL) Assessment in Outcome Studies Ron D. Hays, Ph.D. UCLA/RAND GCRC Summer Course “The.
A Perspective on Family Medicine and End-of-Life and Palliative Care Peter Selwyn, M.D., M.P.H. Professor and Chairman Department of Family & Social Medicine.
The Impact of Lifestyle Modification on the Health-Related Quality of Life of Patients With Reflux Esophagitis Receiving Treatment With a Proton Pump Inhibitor.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Health-Related Quality of Life After Carotid Stenting.
SAT0699 Rapid assessment predicts disease activity improvement in newly diagnosed Rheumatoid Arthritis (RA) Mark Yates*, James Galloway, Neil Snowden,
Psychometric Evaluation of Items Ron D. Hays
NIH: Patient-Reported Outcomes Measurement Information System (PROMIS®) Ron D. Hays Functional Vision and Visual Function November 10, 2016, 8:55-9:15am.
The Minimal Important Difference for St
Presenter: Corina de Jong PhD Department of General Practice,
The numbered points represent individual studies
A Prevention and Treatment Program for Miners
Health-Related Quality of Life Assessment in Outcome Studies
Rhematoid Rthritis Respiratory disorders
OpenNotes in Oregon: An Opportunity for All
OR for baseline predictors of MDA at weeks 12, 24, 48, 96 and 144 by univariate analysis of observed data. OR for baseline predictors of MDA at weeks 12,
The 6 Week Wait: Imaging In Low Back Pain
Estimating Minimally Important Differences (MIDs)
Introduction to Psychometric Analysis of Survey Data
UCLA Department of Medicine
How to Measure Quality of Life
Presentation transcript:

Approaches for Estimating Minimally Important Differences Ron D. Hays, Ph.D. January 12, 2004 (8:50-9:10am) Minimal Clinically Important Differences in COPD Beach House, Bal Harbor, Florida National Jewish Medical and Research Center

2 Magnitude of HRQOL Change Should Parallel Underlying Change

3 How Evaluated u External anchor to determine there has been “minimal” change –Self-report –Provider report –Clinical measure –Intervention u Estimate change in HRQOL among those with minimal change on anchor

4 Change in Physical Function by Size of Intervention

5 Some Anchors are Better than Others for MID Estimation

6 Self-Report Anchor u People who report a “minimal” change u How is your physical health now compared to 4 weeks ago? u Much improved; Moderately Improved; u Minimally Improved; u No Change; u Minimally Worse; u Moderately Worse; Much Worse

7 Example Use of Self-Report Anchor in COPD u Compared to Jack, my ability to walk is: –Much better; Somewhat better; A little bit better; About the same; A little bit worse; Somewhat worse; Much worse u Determined how much actual walking distance had to differ, on average, for patients to rate themselves as walking either a little bit better or “a little bit worse. Redelmeier, D. A. et al., 1997, Am J Respir Crit Care Med

8 Example with Multiple Anchors u 693 RA clinical trial participants evaluated at baseline and 6-weeks post-treatment. u Five anchors: –1) patient global self-report; –2) physician global report; –3) pain self-report; –4) joint swelling; –5) joint tenderness Kosinski, M. et al. (2000). Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis and Rheumatism, 43,

9 Patient and Physician global reports u How the patient is doing, considering all the ways that RA affects him/here? Very good (asymptomatic and no limitation of normal activities) Good (mild symptoms and no limitation of normal activities) Fair (moderate symptoms and limitation of normal activities) Poor (severe symptoms and inability to carry out most normal activities) Very poor (very severe symptoms that are intolerable and inability to carry out normal activities)

10 Pain self-report u 10 centimeter visual analog scale u 0 = no pain, 10 = severe pain

11 Threshold on Self-Report and Physician Report Anchors Used for MID estimation u Patient and physician global reports –Improvement of 1 level over time. u Pain self-report –Improvement of 1-20% over time.

12 Joint swelling and tenderness anchors u Number of swollen and tender joints u Threshold for MID estimation = 1-20% improvement over time

13 Recommendations u Use multiple anchors u Use anchors that represent minimal change u Report average across anchors and studies, range, and SD u Consider that it can be easier to conclude that a difference is clearly or obviously important than it is to say one is always unimportant (grey area).

14 Preparation of materials for this presentation was supported in part by funding from the UCLA/DREW Project EXPORT, National Institutes of Health, National Center on Minority Health & Health Disparities, (P20-MD ) and the UCLA Center for Health Improvement in Minority Elders / Resource Centers for Minority Aging Research, National Institutes of Health, National Institute of Aging, (AG ).

15 Appendix: Terminology u Minimally Important Difference (MID) u Minimal difference (MD) u Minimally Detectable Difference (MDD) u Clinically Important Difference (CID)